Abstract
While remdesivir has garnered much hope for its moderate anti-Covid-19 effects, its parent nucleoside, GS-441524, has been overlooked. Pharmacokinetic analysis of remdesivir evidences premature serum hydrolysis to GS-441524; GS-441524 is the predominant metabolite reaching the lungs. With its synthetic simplicity and in vivo efficacy in the veterinary setting, we contend that GS-441524 is superior to remdesivir for Covid-19 treatment.
Original language | English (US) |
---|---|
Pages (from-to) | 1361-1366 |
Number of pages | 6 |
Journal | ACS Medicinal Chemistry Letters |
Volume | 11 |
Issue number | 7 |
DOIs | |
State | Published - Jul 9 2020 |
Keywords
- Covid-19
- Prodrug
- drug delivery
- metabolism
- remdesivir
ASJC Scopus subject areas
- Biochemistry
- Drug Discovery
- Organic Chemistry